Lifeway Foods, Inc. - Common Stock (LWAY)
22.58
0.00 (0.00%)
Lifeway Foods Inc specializes in the production and sale of fermented dairy products, particularly focusing on kefir, a probiotic-rich beverage known for its health benefits
The company is dedicated to promoting wellness through its diverse range of nutritious products, which include various flavors of kefir, yogurt, and other dairy alternatives. Lifeway prioritizes high-quality ingredients and sustainable practices, aiming to cater to health-conscious consumers seeking natural and functional food options. Through innovation and a commitment to community health, Lifeway Foods continues to expand its product offerings and reach in the competitive food industry.
![](https://cdn.benzinga.com/files/images/story/2024/11/20/Business-Mans-Hand-Recommending-Contract.jpeg?width=1200&height=800&fit=crop)
Lifeway Foods shares fall after rejecting Danone's $27 per share acquisition offer, citing undervaluation and prioritizing growth.
Via Benzinga · November 20, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/15/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/11/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 11, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/11/Nvidia--Palantir--Clover-Health--Joby-Av.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 11, 2024
![](https://g.foolcdn.com/editorial/images/787044/1-arrow-angles-up-on-a-green-stock-chart.jpg)
There's plenty of trouble and family drama going on up at the Chicago-land kefir company this morning.
Via The Motley Fool · August 13, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/13/Business-Analyst-Checking-In-Financial-S.jpeg?width=1200&height=800&fit=crop)
Lifeway Foods' shares jumped after Q2 earnings exceeded expectations, driven by strong volume growth in Lifeway Kefir. Also, Edward and Ludmila Smolyansky file consent statement to change leadership at Lifeway Foods.
Via Benzinga · August 13, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
LWAY stock results show that Lifeway Foods beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 13, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 22, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
LWAY stock results show that Lifeway Foods missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024
![](https://cdn.benzinga.com/files/images/story/2024/04/24/Hilton-hotel-sign.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · April 24, 2024
![](/next-assets/images/schema-image-default.png)
As of March 25, 2024, five stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via Benzinga · March 25, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
LWAY stock results show that Lifeway Foods beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 20, 2024
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2024/march/mmc/midday-market-stats-march-202024.png?sfvrsn=fdd5a606_2)
Stocks are cautiously higher ahead of the conclusion of the central bank's policy meeting.
Via Talk Markets · March 20, 2024
![](https://cdn.benzinga.com/files/images/story/2023/11/13/image41_0.jpg?width=1200&height=800&fit=crop)
Edible Garden AG Incorporated (NASDAQEDBL) shares fell on Monday following third-quarter results.
Via Benzinga · November 13, 2023
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga · September 25, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/31/image46.jpg?width=1200&height=800&fit=crop)
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
Via Benzinga · August 31, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/14/22nd_century_group_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.
Via Benzinga · August 14, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_210.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Viomi Technology Co (NASDAQVIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies NASDAQ:VISLNASDAQVISL)
Via Benzinga · March 27, 2023